Source:http://linkedlifedata.com/resource/pubmed/id/17828295
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2008-3-13
|
pubmed:abstractText |
High-risk human papillomavirus (HPV) is a major causative agent of cervical cancer and the E6 and E7 genes encode the major HPV oncoproteins. The E7 protein from high-risk HPV types alters cell cycle progression and represses genes encoding components of the antigen-presentation pathway, suggesting a role for E7 in tumour immune evasion. We show that knockdown of E7 expression in HPV16- and HPV18-transformed cervical carcinoma cells by RNA interference increased expression of major histocompatibility complex (MHC) class I at the cell surface and reduced susceptibility of these cells to natural killer (NK) cells. Tetracycline-regulated induction of HPV16 E7 resulted in reduced expression of cell surface MHC class I molecules and increased NK cell killing. Our results suggest that, for HPV-associated malignancies, reduced MHC class I expression is the result of an active immune evasion strategy that has evolved to assist viral replication.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Papillomavirus E7 Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/oncogene protein E7, Human...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1476-5594
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
13
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1794-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17828295-Cells, Cultured,
pubmed-meshheading:17828295-Female,
pubmed-meshheading:17828295-HeLa Cells,
pubmed-meshheading:17828295-Histocompatibility Antigens Class I,
pubmed-meshheading:17828295-Human papillomavirus 16,
pubmed-meshheading:17828295-Human papillomavirus 18,
pubmed-meshheading:17828295-Humans,
pubmed-meshheading:17828295-Killer Cells, Natural,
pubmed-meshheading:17828295-Oncogene Proteins, Viral,
pubmed-meshheading:17828295-Papillomavirus E7 Proteins,
pubmed-meshheading:17828295-Papillomavirus Infections,
pubmed-meshheading:17828295-Tumor Escape,
pubmed-meshheading:17828295-Uterine Cervical Neoplasms
|
pubmed:year |
2008
|
pubmed:articleTitle |
High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells.
|
pubmed:affiliation |
Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|